Tetraethylammonium potentiation of insulin release and inhibition of rubidium efflux in pancreatic islets.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D010477:Perfusion; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D012413:Rubidium / Q000378:metabolism*; D013757:Tetraethylammonium Compounds / Q000494:pharmacology*
D007328:Insulin; D013757:Tetraethylammonium Compounds; D001285:Atropine; D011433:Propranolol; D005947:Glucose; D012413:Rubidium